Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Arnold

Showing results (121-130 of 234) with videos related to

Pageof 24
Sort By:
Journal of Cancer Research and Clinical Oncology|May 13, 2014
Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trialHans-Joachim Schmoll, Burghardt Wittig, Dirk Arnold, et al.
Clinical Colorectal Cancer|March 29, 2022
"Global Multidisciplinary Team Meetings": Challenging Cases Virtual Forums from the International Multidisciplinary Anal Cancer Conference (IMACC)Eva Segelov, Marianne Grønlie Guren, David Sebag-Montefiore, et al.
JMIR Research Protocols|April 23, 2020
Clinical Application of Radioembolization in Hepatic Malignancies: Protocol for a Prospective Multicenter Observational StudyThomas Helmberger, Dirk Arnold, José I Bilbao, et al.
British Journal of Cancer|November 30, 2018
Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancerFotios Loupakis, Herbert I Hurwitz, Leonard Saltz, et al.
European Journal of Translational Myology|November 13, 2024
Deceleration of denervated facial muscle atrophy through functional electrical stimulation: a sonographic quantification in patients with facial nerve paralysisGabriel Meincke, Johannes Krauß, Maren Geitner, et al.
International Journal of Radiation Oncology, Biology, Physics|September 21, 2007
Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancerClaus Rödel, Dirk Arnold, Matthias Hipp, et al.
BMC Cancer|August 11, 2012
Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study groupAnke Reinacher-Schick, Karsten Schulmann, Dominik P Modest, et al.
Oncology Research and Treatment|February 14, 2017
Baseline and On-Treatment Markers Determining Prognosis of First-Line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal CancerJulia Quidde, Laura Denne, Andreas Kutscheidt, et al.
Restorative Neurology and Neuroscience|November 24, 2025
Home-based Functional Electrical Stimulation for Treatment of Patients with Facial Nerve ParalysisMaren Geitner, Jonas Ballmaier, Johannes Krauß, et al.
Journal of Clinical Pathology|May 29, 2012
PTEN deletion is rare but often homogeneous in gastric cancerSormeh Mina, Benjamin A Bohn, Ronald Simon, et al.
Pageof 24

Showing results (121-130 of 234) with videos related to

Sort By:
Pageof 24
Journal of Cancer Research and Clinical Oncology|May 13, 2014
Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trialHans-Joachim Schmoll, Burghardt Wittig, Dirk Arnold, et al.
Clinical Colorectal Cancer|March 29, 2022
"Global Multidisciplinary Team Meetings": Challenging Cases Virtual Forums from the International Multidisciplinary Anal Cancer Conference (IMACC)Eva Segelov, Marianne Grønlie Guren, David Sebag-Montefiore, et al.
JMIR Research Protocols|April 23, 2020
Clinical Application of Radioembolization in Hepatic Malignancies: Protocol for a Prospective Multicenter Observational StudyThomas Helmberger, Dirk Arnold, José I Bilbao, et al.
British Journal of Cancer|November 30, 2018
Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancerFotios Loupakis, Herbert I Hurwitz, Leonard Saltz, et al.
European Journal of Translational Myology|November 13, 2024
Deceleration of denervated facial muscle atrophy through functional electrical stimulation: a sonographic quantification in patients with facial nerve paralysisGabriel Meincke, Johannes Krauß, Maren Geitner, et al.
International Journal of Radiation Oncology, Biology, Physics|September 21, 2007
Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancerClaus Rödel, Dirk Arnold, Matthias Hipp, et al.
BMC Cancer|August 11, 2012
Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study groupAnke Reinacher-Schick, Karsten Schulmann, Dominik P Modest, et al.
Oncology Research and Treatment|February 14, 2017
Baseline and On-Treatment Markers Determining Prognosis of First-Line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal CancerJulia Quidde, Laura Denne, Andreas Kutscheidt, et al.
Restorative Neurology and Neuroscience|November 24, 2025
Home-based Functional Electrical Stimulation for Treatment of Patients with Facial Nerve ParalysisMaren Geitner, Jonas Ballmaier, Johannes Krauß, et al.
Journal of Clinical Pathology|May 29, 2012
PTEN deletion is rare but often homogeneous in gastric cancerSormeh Mina, Benjamin A Bohn, Ronald Simon, et al.
Pageof 24